Algorithm Sciences, a Laidlaw Venture Partners Portfolio : v

NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Laidlaw Venture Partners (“LVP”), the venture capital arm of Laidlaw & Company (UK) Ltd., today announced...

Related Keywords

United States , United Kingdom , American , Matthew Duffy , Jason Assad , Gary Gemignani , Michael Tilton , Anthony Zook , Matt Duffy , Securities Investor Protection Corporation , Novartis , Arthur Andersen Co , Biosig Technologies Inc Nasdaq , Astrazeneca , Board Of Voltron Therapeutics Inc , Biodel Inc , Laidlaw Company United Kingdom Ltd , Algorithm Sciences Inc , Synergy Pharmaceuticals Inc , Bausch Health , Astrazeneca Plc Mr , National Pharmaceutical Council , Financial Conduct Authority , Laidlaw Company Uk Ltd , Laidlaw Private Equity , Laidlaw Company International , Pennsylvania Division Of The American Cancer Society , Albireo Ltd He , Laidlaw Company , Algorithm Sciences , Frostburg State University , Venture Partners , Chief Executive Officer , David Cavalier , Chief Operating Officer , Chief Financial Officer , Executive Chairman , North American , Executive Vice President , Astrazeneca Plc , Biosig Technologies , Voltron Therapeutics , Ribx Pharmaceuticals , Pennsylvania Division , American Cancer Society , Frostburg State , Synergy Pharmaceuticals , Arthur Andersen , Laidlaw Venture Partners , Company International Limited , Wealth Management , Laidlaw Private , Laidlaw And Company Uk Ltd , Venture Capital ,